ストックスクリーナーアプリを入手
7.92
0.38%
0.03
アフターアワーズ：
7.92
前日終値:
$7.89
開ける：
$7.87
24時間の取引高:
167.05K
Relative Volume:
0.56
時価総額：
$530.45M
収益：
$555.06M
当期純損益:
$-39.48M
株価収益率:
-13.20
EPS:
-0.6
ネットキャッシュフロー:
$29.05M
1週間 パフォーマンス:
+2.72%
1か月 パフォーマンス:
+6.17%
6か月 パフォーマンス:
+20.55%
1年 パフォーマンス:
-21.27%
1日の値動き範囲:
$7.7501
$7.93
1週間の範囲:
$7.75
$8.345
52週間の値動き範囲:
$5.81
$11.25
Bioventus Inc Stock (BVS) Company Profile
名前
Bioventus Inc
セクター
電話
(919) 474-6700
住所
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
7.92 | 528.44M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-12-07 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | アップグレード | Craig Hallum | Hold → Buy |
| 2022-11-22 | ダウングレード | Craig Hallum | Buy → Hold |
| 2022-11-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 開始されました | Craig Hallum | Buy |
| 2021-11-15 | 再開されました | Morgan Stanley | Overweight |
| 2021-11-10 | 再開されました | JP Morgan | Overweight |
| 2021-07-01 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-08 | 開始されました | Goldman | Buy |
| 2021-03-08 | 開始されました | JP Morgan | Overweight |
| 2021-03-08 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Bioventus Inc (BVS) 最新ニュース
Discipline and Rules-Based Execution in BVS Response - Stock Traders Daily
US Market Recap: What is Bioventus Incs valuation compared to sectorFed Meeting & Weekly Setup with ROI Potential - baoquankhu1.vn
Entry Recap: Can CNVS maintain sales growthGap Down & Accurate Technical Buy Alerts - baoquankhu1.vn
Published on: 2026-01-23 16:18:52 - baoquankhu1.vn
Bioventus (NYSE:BVS) Trading Up 3.8%Still a Buy? - MarketBeat
Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference - Defense World
Bioness $110M Sale Suit Heads to $8.9M Deal - Law360
Investment Recap: Is Bioventus Inc in a bullish channel2025 Risk Factors & High Conviction Buy Zone Picks - baoquankhu1.vn
Institutional investors own a significant stake of 36% in Bioventus Inc. (NASDAQ:BVS) - Yahoo Finance
Bioventus (NASDAQ:BVS) Stock Price Down 0.6%Should You Sell? - MarketBeat
Market Catalysts: Is Bioventus Inc currently under institutional pressure2025 Winners & Losers & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Trade Recap: Is Bioventus Inc stock gaining market shareProduct Launch & Safe Capital Preservation Plans - Bộ Nội Vụ
Recent uptick might appease Bioventus Inc. (NASDAQ:BVS) institutional owners after losing 13% over the past year - simplywall.st
What Wall Street predicts for Bioventus Inc. stock priceShort Setup & Weekly Sector Rotation Insights - ulpravda.ru
Why Bioventus Inc. stock could rally in 20252025 Short Interest & Accurate Buy Signal Alerts - Улправда
Will Bioventus Inc. stock deliver consistent dividendsDay Trade & High Accuracy Trade Alerts - Улправда
Is Bioventus Inc. stock gaining market share2025 Earnings Impact & Breakout Confirmation Trade Signals - Улправда
Can Bioventus Inc. stock sustain revenue growthJuly 2025 Spike Watch & Community Consensus Stock Picks - Улправда
How risky is Bioventus Inc. stock nowJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Will Bioventus Inc. stock return to pre crisis levelsJuly 2025 Opening Moves & High Accuracy Buy Signal Tips - Улправда
Why Bioventus Inc. stock could outperform in 2025Portfolio Value Summary & Low Risk High Win Rate Picks - Улправда
Hyaluronic Acid Products Market to Reach $20 billion, Globally, - openPR.com
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
(BVS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Will Bioventus Inc stock deliver consistent dividends2025 Earnings Impact & Growth Focused Investment Plans - moha.gov.vn
Bioventus (NYSE:BVS) Trading Down 1.1%Time to Sell? - MarketBeat
Why (BVS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Aug Analyst Calls: Why Bioventus Inc stock could outperform in 2025Gap Up & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Why Bioventus Inc. stock is favored by top institutionsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
Will Bioventus Inc. stock benefit from automationJuly 2025 Institutional & Reliable Price Breakout Alerts - DonanımHaber
Will Bioventus Inc. stock rally after Fed decisionsJuly 2025 Opening Moves & Target Return Focused Stock Picks - Улправда
Is Bioventus Inc. stock resilient to inflation2025 Market WrapUp & Community Consensus Picks - Улправда
BVS (Bioventus) Purchase Of Investment : $0.0 Mil (TTM As of Sep. 2025) - GuruFocus
Bioventus (BVS) Receives a Buy from Canaccord Genuity - The Globe and Mail
Bioventus Earnings Notes - Trefis
(BVS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bioventus Reports Strong Q3 2025 Financial Performance - MSN
Bioventus (NYSE:BVS) Director Sells $75,700.00 in Stock - MarketBeat
Bioventus Director Guy P Nohra Sells 10,000 Shares - TradingView — Track All Markets
Dir Nohra Sells 10,000 ($75.7K) Of Bioventus Inc [BVS] - TradingView — Track All Markets
Divisadero Street Capital Management LP Decreases Stock Position in Bioventus Inc. $BVS - MarketBeat
Geode Capital Management LLC Has $6.98 Million Stake in Bioventus Inc. $BVS - Defense World
American Century Companies Inc. Grows Stock Holdings in Bioventus Inc. $BVS - Defense World
Buy Signal: Why Bioventus Inc stock is favored by top institutionsQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Bioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare ConferenceSlideshow - Seeking Alpha
Dir Nohra Files To Sell 10,000 Of Bioventus Inc [BVS] - TradingView
Is It Too Late To Consider Buying Bioventus Inc. (NASDAQ:BVS)? - Yahoo Finance
Will Bioventus Inc. stock reach Wall Street targetsTrade Exit Summary & Real-Time Market Sentiment Reports - Newser
Will Bioventus Inc. stock see insider buyingWeekly Stock Report & Short-Term High Return Ideas - Newser
Bioventus Inc (BVS) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
0.96%
大文字化:
|
ボリューム (24 時間):